ReviewChemical reviews2025
Supramolecular Materials and Strategies for Bioorthogonal Chemical Transformations.
Review in Chemical reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineered live bacteria for liver diseases and gut-liver axis disorders: from genetic modification to advanced delivery systems.Journal of nanobiotechnology · 2026Review
- Enzyme-Instructed Self-Assembly for Cellular Supramolecular Chemistry.Chemistry, an Asian journal · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bioorthogonal reactions play a key role in controlled chemical transformations in living systems and are therefore applied to a diverse area of biological and medical applications. However, these applications can be limited by poor selectivity, slow kinetics under biological conditions, and intrinsic incompatibility between the introduced materials and the cellular environment. An emerging strategy for greater functional control over bioorthogonal transformations is the employment of supramolecular strategies or constructs. Herein, we focus on synthetic supramolecular systems that (i) improve biocompatibility by shielding reactive species within protective supramolecular constructs from harsh biological environments; (ii) allow for integration of subcellular targeting moieties; (iii) reduce toxicity; (iv) accelerate reaction rates through molecular preorganization; (v) explore entirely new tools, such as catalysis regulated by controlled stimuli at a functionalized surface. Through rational integration of these supramolecular strategies, bioorthogonal reactions could achieve enhanced precision, faster kinetics, and targeted reactivity within specific tissues, cells, or organelles, subsequently paving the way for further applications in chemical biology and therapeutic interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.